ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infection - Leung, D H; Yao, B; Viani, R M (Journal of hepatology, 2017)
et al.